Is it human subjects’ research? |
Individuals often serve as subjects, with focus on safety and individual outcomes |
Subjects can be individuals, groups, or entire health systems. Ethical review may be needed for interventions affecting broader systems |
Ethical review often focuses on individual participant rights and well-being |
Ethical review boards may need to assess impact on communities, organizations, and health delivery systems. Waiving review for quality improvement should be carefully considered |
Who should provide informed consent? |
Consent typically obtained from individual participants |
Consent considerations extend to healthcare providers, administrators, and patients. Scope includes potential impact on systems and practices in implementation |
Consent form outlines study purpose, procedures, risks, and benefits for individuals |
Consent may cover changes at the system level, understanding potential effects on multiple stakeholders |
Is equipoise necessary? |
Control groups often used to compare new interventions |
Balancing equipoise can involve changes in practices, necessitating ethical reasoning for control groups. Uncertainty in scientific merit is important, but implementation context adds complexity |
Equipoise considers balancing risks and benefits for individual participants |
Risk-benefit assessment includes potential system-level and societal impact, as well as individual well-being |
How can scientific rigor be protected in routine care settings? |
Rigor focuses on experimental design, data collection, and analysis |
Rigor includes evaluating how interventions integrate into real-world contexts. Added challenge of assessing system-level outcomes |
Focus on addressing potential biases from study design and analysis |
Consideration of biases extends to the impact of biases on healthcare delivery and system-level outcomes. Balancing scientific rigor with the practical considerations of diverse stakeholders is challenging. |